These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 6867876

  • 1. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal.
    Findlay GH.
    S Afr Med J; 1983 Jul 09; 64(2):54-6. PubMed ID: 6867876
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
    Pehamberger H, Esca SA, Holubar K.
    Z Hautkr; 1980 Jan 15; 55(2):68-78. PubMed ID: 7405336
    [Abstract] [Full Text] [Related]

  • 3. Etretinate (Tigason) for skin disease.
    Drug Ther Bull; 1983 Feb 11; 21(3):9-11. PubMed ID: 6839967
    [No Abstract] [Full Text] [Related]

  • 4. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G, Meyer-Hamme S, Ippen H.
    Arch Dermatol; 1982 Feb 11; 118(2):97-100. PubMed ID: 7059226
    [Abstract] [Full Text] [Related]

  • 5. Oral retinoid (Ro 10-9359) in children with lamellar ichthyosis, epidermolytic hyperkeratosis and symmetrical progressive erythrokeratoderma.
    Tamayo L, Ruiz-Maldonado R.
    Dermatologica; 1980 Feb 11; 161(5):305-14. PubMed ID: 6449393
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
    Burge SM, Wilkinson JD, Miller AJ, Ryan TJ.
    Br J Dermatol; 1981 Jun 11; 104(6):675-9. PubMed ID: 7248178
    [Abstract] [Full Text] [Related]

  • 7. Retinoids in disorders of keratinization: their use in adults.
    Happle R, van de Kerkhof PC, Traupe H.
    Dermatologica; 1987 Jun 11; 175 Suppl 1():107-24. PubMed ID: 2961628
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Disabling errors of skin keratinization. Ichthyosiform erythrodermas and the 'half-baby syndrome' treated with an aromatic retinoid.
    Findlay GH.
    S Afr Med J; 1981 May 09; 59(20):717-20. PubMed ID: 7013111
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Etretinat (Tigason). A vitamin A acid derivative for peroral treatment of hyperkeratotic dermatoses].
    Foged EK, Laurberg G, Schmidt H.
    Ugeskr Laeger; 1983 Jun 06; 145(23):1797-9. PubMed ID: 6879814
    [No Abstract] [Full Text] [Related]

  • 17. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J.
    Acta Derm Venereol Suppl (Stockh); 1982 Jun 06; 101():1-29. PubMed ID: 6954822
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Keratosis palmaris et plantaris areata Siemens. Therapeutic experiments with aromatic retinoid Ro 10-9359].
    Luderschmidt C, Plewig G.
    Hautarzt; 1980 Feb 06; 31(2):96-9. PubMed ID: 6447125
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.